Lifetime hormonal factors may predict late-life depression in women

International Psychogeriatrics

Volumn 20, Issue 6, 2008, Pages 1203-1218

  Ryan, Joanne ^a   Carrière, Isabelle ^b   Scali, Jacqueline ^b   Ritchie, Karen ^b   Ancelin, Marie Laure ^b  

^a Montpellier 1 University   (France)

^b NONE

Author keywords

Depression; Estrogen; Late life; Lifetime hormonal exposure

Indexed keywords

HORMONE;

ACADEMIC ACHIEVEMENT; AGED; AGING; ARTICLE; DEPRESSION; FEMALE; HORMONAL REGULATION; HORMONAL THERAPY; HUMAN; LIFESPAN; MAJOR CLINICAL STUDY; MENOPAUSE; MOOD; ONSET AGE; ORAL CONTRACEPTION; PREVALENCE; RISK FACTOR; STATISTICAL ANALYSIS; WOMEN'S HEALTH;

ADULT; AGE FACTORS; CONTRACEPTIVES, ORAL, HORMONAL; DEPRESSIVE DISORDER, MAJOR; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; LIFE CHANGE EVENTS; MENARCHE; MENOPAUSE; MENSTRUAL CYCLE; PARITY; PERIMENOPAUSE; PREGNANCY; PREMENOPAUSE; PREVALENCE; PROBABILITY; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; REPRODUCTIVE HISTORY; RISK FACTORS;

EID: 54049083403     PISSN: 10416102     EISSN: 1741203X     Source Type: Journal    
DOI: 10.1017/S1041610208007412     Document Type: Article

References (30)

1. Ancelin, M. L., Scali, J. and Ritchie, K. (2007). Hormonal therapy and depression: Are we overlooking an important therapeutic alternative? Journal of Psychosomatic Research, 62, 473-485.
2. Anderson, G. L. et al. (2004). Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA, 291, 1701-1712.
3. Andrade, T. G., Nakamuta, J. S., Avanzi, V. and Graeff, F. G. (2005). Anxiolytic effect of estradiol in the median raphe nucleus mediated by 5-HT1A receptors. Behavioural Brain Research, 163, 18-25.
4. Bean, J. A., Leeper, J. D., Wallace, R. B., Sherman, B. M. and Jagger, H. (1979). Variations in the reporting of menstrual histories. American Journal of Epidemiology, 109, 181-185.
5. Berkman, L. F. et al. (1986). Depressive symptoms in relation to physical health and functioning in the elderly. American Journal of Epidemiology, 124, 372-388.
6. Bloch, M., Schmidt, P. J., Danaceau, M., Murphy, J., Nieman, L. and Rubinow, D. R. (2000). Effects of gonadal steroids in women with a history of postpartum depression. American Journal of Psychiatry, 157, 924-930.
7. Bromberger, J. T. et al. (2007). Depressive symptoms during the menopausal transition: the Study of Women's Health Across the Nation (SWAN). Journal of Affective Disorders, 103, 267-272.
8. Campagne, D. M. and Campagne, D. M. (2007). The premenstrual syndrome revisited. European Journal of Obstetrics and Gynaecology and Reproductive Biology, 130, 4-17.
9. Clavel-Chapelon, F. (2002). Cumulative number of menstrual cycles and breast cancer risk: results from the E3N cohort study of French women. Cancer Causes and Control, 13, 831-838.
10. Cohen, L. S., Soares, C. N., Poitras, J. R., Prouty, J., Alexander, A. B. and Shifren, J. L. (2003). Short-term use of estradiol for depression in perimenopausal and postmenopausal women: a preliminary report. American Journal of Psychiatry, 160, 1519-1522.
11. Erdincler, D., Bugay, G., Ertan, T. and Eker, E. (2004). Depression and sex hormones in elderly women. Archives of Gerontology and Geriatrics, 39, 239-244.
12. Folstein, M. F., Folstein, S. E. and McHugh, P. R. (1975). "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189-198.
13. Harlow, B. L., Wise, L. A., Otto, M. W., Soares, C. N. and Cohen, L. S. (2003). Depression and its influence on reproductive endocrine and menstrual cycle markers associated with perimenopause: the Harvard Study of Moods and Cycles. Archives of General Psychiatry, 60, 29-36.
14. Kalache, A., Maguire, A. and Thompson, S. G. (1993). Age at last full-term pregnancy and risk of breast cancer. The Lancet, 341, 33-36.
15. Katz, S., Ford, A. B., Moskowitz, R. W. and Jaffee, M. W. (1963). Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA, 195, 94-99.
16. Key, T. J., Verkasalo, P. K. and Banks, E. (2001). Epidemiology of breast cancer. Lancet Oncology, 2, 133-140.
17. Kotz, K., Alexander, J. L. and Dennerstein, L. (2006). Estrogen and androgen hormone therapy and well-being in surgically postmenopausal women. Journal of Women's Health (Larchmont), 15, 898-908.
18. Lawton, M. P. and Brody, E. M. (1969). Assessment of older people: self-maintaining and instrumental activities of daily living. The Gerontologist, 9, 179-186.
19. Low, L. F., Anstey, K. J., Jorm, A. F., Rodgers, B. and Christensen, H. (2005). Reproductive period and cognitive function in a representative sample of naturally postmenopausal women aged 60-64 years. Climacteric, 8, 380-389.
20. McLay, R. N., Maki, P. M. and Lyketsos, C. G. (2003). Nulliparity and late menopause are associated with decreased cognitive decline. Journal of Neuropsychiatry and Clinical Neurosciences, 15, 161-167.
21. Michaelsson, K., Baron, J. A., Farahmand, B. Y., Persson, I. and Ljunghall, S. (1999). Oral-contraceptive use and risk of hip fracture: a case-control study. The Lancet, 353, 1481-1484.
22. Nguyen, T. V., Jones, G., Sambrook, P. N., White, C. P., Kelly, P. J. and Eisman, J. A. (1995). Effects of estrogen exposure and reproductive factors on bone mineral density and osteoporotic fractures. Journal of Clinical Endocrinology and Metabolism, 80, 2709-2714.
23. Radloff, L. S. and Locke, B. Z. (1986). The community mental health assessment survey and CES-D scale. In M. M. Weissman and J. K. Myers (eds.), Community Surveys of Psychiatric Disorders. New Brunswick, NJ: Rutgers University Press.
24. Ribet, C. and Derriennic, F. (1999). Age, working conditions and sleep disorders: a longitudinal analysis in the French cohort E.S.T.E.V. Sleep, 22, 491-504.
25. Ritchie, K. et al. (2004). Prevalence of DSM-IV psychiatric disorder in the French elderly population. British Journal of Psychiatry, 184, 147-152.
26. Schiff, R., Bulpitt, C. J., Wesnes, K. A. and Rajkumar, C. (2005). Short-term transdermal estradiol therapy, cognition and depressive symptoms in healthy older women. A randomised placebo controlled pilot cross-over study. Psychoneuroendocrinology, 30, 309-315.
27. Schmidt, P. J., Nieman, L. K., Danaceau, M. A., Adams, L. F. and Rubinow, D. R. (1998). Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. The New England Journal of Medicine, 338, 209-216.
28. Steiner, M., Dunn, E. and Born, L. (2003). Hormones and mood: from menarche to menopause and beyond. Journal of Affective Disorders, 74, 67-83.
29. Whooley, M. A., Grady, D. and Cauley, J. A. (2000). Postmenopausal estrogen therapy and depressive symptoms in older women. Journal of General Internal Medicine, 15, 535-541.
30. Young, E. A., Midgley, A. R., Carlson, N. E. and Brown, M. B. (2000). Alteration in the hypothalamic-pituitary-ovarian axis in depressed women. Archives of General Psychiatry, 57, 1157-1162.